In re Oxford Health Plans Inc., Securities Litigation

182 F.R.D. 42, 1998 U.S. Dist. LEXIS 10694, 1998 WL 400741
CourtDistrict Court, S.D. New York
DecidedJuly 15, 1998
DocketNo. MDL-1222
StatusPublished
Cited by119 cases

This text of 182 F.R.D. 42 (In re Oxford Health Plans Inc., Securities Litigation) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Oxford Health Plans Inc., Securities Litigation, 182 F.R.D. 42, 1998 U.S. Dist. LEXIS 10694, 1998 WL 400741 (S.D.N.Y. 1998).

Opinion

[43]*43MEMORANDUM DECISION

BRIEANT, District Judge.

Presently before the Court in these cases alleging securities fraud, which have been consolidated for pre-trial purposes, are a number of motions relating to the designation of lead plaintiff and approval of lead counsel under the provisions of section 21D(a)(3)(B) of the Securities and Exchange Act of 1934 (“Exchange Act”), as amended by the Private Securities Litigation Reform Act of 1995 (the “PSLRA” or “the Act”), 15 U.S.C. § 78u-4. A hearing was held on June 11,1998 and decision reserved.

On April 28, 1998 the Judicial Panel on Multidistrict Litigation filed an order consolidating the 52 separate actions in this litigation (38 from the District of Connecticut, 9 from the Southern District of New York, 4 from the Eastern District of New York and 1 from the Eastern District of Arkansas) and transferring them to this Court for pretrial purposes pursuant to 28 U.S.C. § 1407. Two additional cases have since been filed in this District.1 For the reasons discussed below, this Court now grants the motions of the Public Employee’s Retirement Association of Colorado, the Yogel Group (as defined below) and PBHG to be appointed co-lead plaintiffs for the securities fraud cases. The Court also approves the plaintiffs’ respective choices — Grant & Eisenhofer, P.A., Milberg Weiss Bershad Hynes & Lerach, L.L.P., and Chitwood & Harley — to act as co-lead counsel. Such counsel shall assemble and consult with an Executive Committee as set forth below.

I. The Private Securities Litigation Reform Act of 1995

The PSLRA, which altered the procedures for bringing class actions under the federal securities laws, was enacted in response to a variety of perceived abuses of the class action procedure. H.R.Rep. No. 104-369, at 31 (1995) reprinted in 1996 U.S.C.C.A.N. 730. Among other things Congress was concerned that the lead plaintiff in class action lawsuits was being determined by plaintiffs’ lawyers’ race to the courthouse. See S.Rep. No. 104-98 (1995) reprinted in 1996 U.S.C.C.A.N. 679. In enacting the PSLRA, Congress intended to “increase the likelihood that parties with significant holdings in issuers, whose interests are more strongly aligned' [44]*44with the class of shareholders, will participate in the litigation and exercise control over the selection and actions of plaintiffs counsel.” H.R.Rep. No. 104-369, at 32 (1995) reprinted in 1996 U.S.C.C.A.N. at 731.

The PSLRA directs the Court to “appoint as lead plaintiff the member or members of the purported plaintiff class that the court determines to be most capable of adequately representing the interests of the class.” 15 U.S.C. § 78u-4(a)(3)(B)(i) (emphasis added). The Act creates a “rebuttable presumption ... that the most adequate plaintiff ... is the person or group of persons that (aa) has either filed the complaint or made a motion in response to a notice ... (bb) in the determination of the court, has the largest financial interest in the relief sought by the class; and (cc) otherwise satisfies the requirements of Rule 23 of the Federal Rules of Civil Procedure.” 15 U.S.C. § 78u-4(a) (3)(B)(iii) (I).

The presumption may be rebutted “only upon proof by a member of the purported plaintiff class that the presumptively most adequate plaintiff — (aa) will not fairly and adequately represent the interests of the class; or (bb) is subject to unique defenses that render such plaintiff incapable of adequately representing the class.” 15 U.S.C. § 78u-4(a)(3)(B)(iii)(II). Before obtaining discovery in this regard, the objecting plaintiff must demonstrate a reasonable basis for a finding “that the presumptively most adequate plaintiff is incapable of representing the class.” 15 U.S.C. § 78u-4(a)(3)(B)(iv)

Finally, the PSLRA states that “[t]he most adequate plaintiff shall, subject to the approval of the court, select and retain counsel to represent the class.” 15 U.S.C. § 78u-4(a)(3)(B)(v).

II. Background

Oxford Health Plans, Inc. (“Oxford”) is a Delaware corporation engaged in the managed health care business, providing health benefit plans in New York, New Jersey, Pennsylvania, Connecticut and New Hampshire. The individual defendants named in the complaints were the principal executive officers and directors of Oxford.

The securities fraud actions which have been consolidated in this Court were brought on behalf of persons and entities who purchased Oxford common stock during varying alleged class periods ranging from November 1996 through December 1997. The complaints generally claim violations of §§ 10(b) and 20(a) of the Securities and Exchange Act and Rule 10b-5 promulgated thereunder by the SEC. Specifically the plaintiffs allege that Oxford failed to disclose ongoing problems with its computer system and its resulting financial deterioration, while substantial insider trading occurred.

III. The Movants for Appointment as Lead Counsel

Numerous .motions seeking lead plaintiff status in this action have been filed, some of which were withdrawn after the cases were consolidated. The Public Employee’s Retirement Association of Colorado (“ColPERA”) appears to have suffered the largest financial loss, followed by the Vogel plaintiffs and the PBHG Funds. This was conceded at the June 11,1998 hearing.

A. ColPERA

ColPERA is a pension fund for state of Colorado employees which moved to be appointed lead counsel on December 22, 1997 alleging losses in excess of $25 million. On January 28, 1998 ColPERA moved for leave to supplement its motion revising its loss, after offsetting for certain gains, to $19,435,-749.25 (using the class period of November 11, 1996-December 12, 1997). On June 4, 1998 ColPERA submitted a proposed order appointing ColPERA as lead plaintiff, Grant & Eisenhofer, P.A. as lead counsel and an executive committee composed of Grant & Eisenhofer as Chair and four other law firms which also made lead plaintiff motions as members (Abbey, Gardy & Squiteri, L.L.P.; Wolf Popper, L.L.P.; Bernstein Litowitz Berger & Grossman, L.L.P.; and Lowey Dannenberg Bemporad & Selinger, P.C.).

B. Vogel

On December 23, 1997 the Vogel plaintiffs (“Vogel”), consisting of approximately 35 individual plaintiffs and entities, filed a motion [45]*45for appointment as lead plaintiff and appointment of Milberg Weiss Bershad Hynes & Lerach, L.L.P., as lead counsel.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
182 F.R.D. 42, 1998 U.S. Dist. LEXIS 10694, 1998 WL 400741, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-oxford-health-plans-inc-securities-litigation-nysd-1998.